Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1W) Sell (1W) ▼ Price Target price Potential
Trevena Inc. 2 23 0 1 €0.15 €6.48 4136.601%
Glycomimetics Inc. 3 6 0 1 €0.15 €9.13 5909.605%
Viking Therapeutics Inc 4 1 0 1 €57.46 - -
Organovo Holdings Inc. 0 9 0 1 €0.54 - -
Minerva Neurosciences Inc. 0 10 0 1 €2.50 - -
Cara Therapeutics Inc. 10 6 0 0 €0.32 €4.61 1330.502%
Karyopharm Therapeutics Inc. 8 1 0 0 €0.69 €5.49 691.580%
T2 Biosystems Inc. 0 4 0 0 €0.16 - -
Atara Biotherapeutics Inc. 2 2 0 0 €0.37 €3.00 716.549%
Coherus Bioscien. 0 2 0 0 €1.25 - -
Bellicum Pharmaceuticals Inc. 0 10 0 0 €0.064 - -
Salarius Pharmaceuticals Inc. 0 1 0 0 €0.39 - -
Rocket Pharmaceuticals Inc 2 1 0 0 ? €32.00 83.961%
Cytomx Therapeutics Inc 2 1 0 0 €1.05 €50.00 4652.852%
Natural Alternat. 19 1 0 0 €4.78 - -
Syros Pharmaceuticals Inc. 9 1 0 0 €1.51 €12.01 695.066%
Agenus Inc. 4 2 0 0 €0.41 €37.02 8846.834%
Aspira Womens Health Inc. 1 1 0 0 €0.87 €4.99 477.156%
Pacific Biosciences of California Inc. 10 4 0 0 €1.28 €9.20 617.429%
Fate Therapeutics Inc. 3 3 0 0 €3.38 €7.31 116.028%